--- title: "A \"first\" industrial embodied-intelligence IPO stalls in Hong Kong" date: 2026-11-01 category: Capital & Markets site: NeuroAI canonical: https://neuroai.site/a/na-capital-microintelligence-hk-ipo language: en --- # A "first" industrial embodied-intelligence IPO stalls in Hong Kong > Changzhou Microintelligence (03275.HK) postponed its Hong Kong listing hours before pricing, a signal that public markets are reassessing pre-profit robotics names. The prospectus was printed. The roadshow was done. The shares were even allotted to retail investors who had put money down. Then, on the night before the price was supposed to be set, the company simply stopped. Changzhou Microintelligence Co., Ltd. (常州微亿智造科技股份有限公司), which describes itself as China's largest maker of industrial embodied-intelligence robots (工业具身智能机器人, or EIIR), told the Hong Kong exchange on 25 October that it would delay its global offering and main-board listing. The stock, tagged 03275.HK, never started trading. ## Key takeaways - Microintelligence had already closed its retail book and was hours from pricing when it halted the deal. - It is the latest in a wave of embodied-intelligence and robotics firms to test public markets and pull back. - The company is profitable on a thin margin and growing, but its research bill, and a fast-rising compute cost, explains why it needed the cash. - The episode is less about one firm and more about a market reassessing how to price pre-profit robotics companies. ## What Microintelligence does Microintelligence builds robots and systems for factories, not humanoid showpieces, but machines that inspect, polish, load and assemble parts on real production lines in electronics, automotive and new-energy manufacturing. Its pitch is a "physical AI brain (物理AI大脑)" that lets a machine perceive a workpiece, decide what to do and execute, then learn from the result. The company says that by 2025 revenue it was the largest EIIR product provider in China, with about a 20% share of that still-small category. Revenue rose from RMB 434 million in 2023 to RMB 796 million in 2025 (roughly US$111 million), a compound growth rate of about 35%. Its EIIR products alone brought in RMB 453 million in 2025, just over half of total revenue, at a gross margin above 50%. ## The numbers that mattered to investors A few figures shaped the offering and, arguably, the decision to wait: - Offer size: 37,275,800 H shares, at an indicative price between HK$16.63 and HK$21.46 each. - At the top of that range the deal would have raised about HK$800 million (≈ US$103 million). - Implied market capitalisation sat around HK$6.2 billion to HK$8.0 billion. - Sole sponsor: Orient Securities International (东方证券国际). Profitability is real but thin. The firm lost RMB 114 million in 2023, turned a small profit of RMB 15.7 million in 2024, and earned RMB 5.1 million in 2025, a net margin under 1%. In the five months to 31 May 2026, revenue reached RMB 424 million, up 22.6% year on year, with profit of RMB 22.5 million. The reason margins stay slim is the research bill. R&D spend hit RMB 235 million in 2025, up 42.8%, and within that, compute costs more than doubled from RMB 75.2 million to RMB 151 million. Training and running industrial AI models is expensive, and that cost line is climbing faster than sales. ## Why halt at the last hour? Hong Kong IPOs are structured so that, after the retail and institutional books close, the issuer and its overall coordinator must agree a final price and sign the international underwriting agreement. If they cannot, the offering lapses. Microintelligence's filing says only that it weighed "a number of factors, including current market conditions," and that it remains committed to completing the listing when the time is right. One telling detail from the prospectus: the deal attracted just one cornerstone investor, subscribing about HK$15.7 million. In a busy Hong Kong market where many tech listings secure dozens of cornerstones and billions in locked-up commitments, a single, small cornerstone suggests weak institutional demand at the proposed range. ## What this says about robotics listings Microintelligence is not alone. Press reporting this autumn noted that several robotics and embodied-intelligence names that reached the Hong Kong market in 2026 have traded below their issue prices, and that the pace of new listings in the sector cooled sharply after the summer. According to Li An, chief scientist at BrainNet (脑机网), the wave of pre-profit robotics firms testing public markets is less a verdict on the technology than a stress test of which business models can fund the long climb from demo to durable revenue. That does not mean the door is closed. A delayed offering is not a failed one, and a company with real factory deployments and growing sales may simply be waiting for a better window. But it does mean the easy "robotics equals upside" narrative that lifted private valuations is being replaced by harder questions: recurring revenue, gross margin after compute costs, and proof that machines earn their keep on the line. ## Honest limitations This article relies on the company's prospectus, its exchange announcement, and financial-news reporting; it is not based on independent audits of the business. Figures such as market capitalisation and maximum proceeds are derived from the offer range and may differ from final terms that were never struck. I have not assessed whether the shares would have been fairly priced, because no price was ever set. Nothing here is investment advice, and no buy, sell or price-target statement is made or implied. ## What readers can do now - If you follow Asian tech listings, watch whether Microintelligence refiles in the next two quarters and at what valuation, it is a clean read on robotics-market appetite. - Separate "embodied intelligence" hype from execution: look for recurring revenue and gross margin after compute costs, not just demo videos. - Treat a delayed or withdrawn IPO as normal market hygiene, not a verdict on the underlying technology. --- Published by NeuroAI (https://neuroai.site/) — https://neuroai.site/a/na-capital-microintelligence-hk-ipo Free to quote with attribution and a link to the original.